Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Givlarri

Drug Genetic Disease

NDC 71336-1001-1

Open in the dashboard

General payments

$222,243

279 payments

Research payments

$1,358,241

94 payments

Through program year 2019, $222,243 in general payments and $1,358,241 in research payments were reported against Givlarri (Genetic Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $222,243 279
2019 Research $1,358,241 94

Breakdown

Who paid General payments · program year 2019
  1. Alnylam Pharmaceuticals Inc. $222,243 279 payments
Top recipients General payments · program year 2019
  1. Manisha Balwani Clinical Genetics (M.D.) · New York, NY $15,611 7% · 23 payments
  2. Pierre Gholam Gastroenterology · Cleveland, OH $13,948 6% · 12 payments
  3. William Chey Gastroenterology · Ann Arbor, MI $12,899 6% · 7 payments
  4. Herbert Bonkovsky Gastroenterology · Winston Salem, NC $11,057 5% · 12 payments
  5. Sean Rudnick Gastroenterology · Charlotte, NC $9,738 4% · 2 payments

The top 5 of 82 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Gastroenterology Internal Medicine $107,942 51% · 27 practitioners
  2. Clinical Genetics (M.D.) Medical Genetics $29,296 14% · 3 practitioners
  3. Hematology Internal Medicine $17,513 8% · 7 practitioners
  4. Pediatrics $7,846 4% · 3 practitioners
  5. Pulmonary Disease Internal Medicine $7,152 3% · 1 practitioner

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Ohio $41,617 19% · 7 recipients
  2. New York $30,970 14% · 10 recipients
  3. North Carolina $29,358 13% · 4 recipients
  4. Michigan $20,432 9% · 3 recipients
  5. Texas $16,374 7% · 4 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

279 general · 94 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record